Scarica l'app Stockscreener
725.91
5.30%
36.56
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IDXX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$689.35
Aprire:
$690.1
Volume 24 ore:
972.43K
Relative Volume:
2.03
Capitalizzazione di mercato:
$57.96B
Reddito:
$4.17B
Utile/perdita netta:
$1.03B
Rapporto P/E:
57.54
EPS:
12.6148
Flusso di cassa netto:
$940.22M
1 W Prestazione:
+5.22%
1M Prestazione:
+13.93%
6M Prestazione:
+44.93%
1 anno Prestazione:
+73.43%
Intervallo 1D:
$688.14
$735.59
Intervallo di 1 settimana:
$665.25
$735.59
Portata 52W:
$356.14
$735.59
Idexx Laboratories Inc Stock (IDXX) Company Profile
Nome
Idexx Laboratories Inc
Settore
Industria
Telefono
(207) 556-0300
Indirizzo
ONE IDEXX DRIVE, WESTBROOK, ME
Confronta IDXX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
725.91 | 55.05B | 4.17B | 1.03B | 940.22M | 12.61 |
|
TMO
Thermo Fisher Scientific Inc
|
587.48 | 215.18B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
227.39 | 156.94B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
A
Agilent Technologies Inc
|
151.25 | 41.12B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
224.90 | 36.97B | 15.90B | 1.28B | 2.21B | 7.2842 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-31 | Aggiornamento | Stifel | Hold → Buy |
| 2025-10-01 | Iniziato | UBS | Neutral |
| 2025-08-05 | Reiterato | BTIG Research | Buy |
| 2025-07-01 | Iniziato | Jefferies | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Outperform |
| 2024-07-25 | Iniziato | BTIG Research | Buy |
| 2024-01-30 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-12-04 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Downgrade | Stifel | Buy → Hold |
| 2022-07-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-07-12 | Iniziato | Piper Sandler | Overweight |
| 2022-05-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-02-08 | Iniziato | Atlantic Equities | Overweight |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-12 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-02-17 | Iniziato | Barclays | Overweight |
| 2019-09-09 | Iniziato | Goldman | Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Buy |
| 2018-11-02 | Reiterato | BofA/Merrill | Buy |
| 2018-05-07 | Reiterato | Stifel | Buy |
| 2018-01-16 | Iniziato | Piper Jaffray | Overweight |
| 2017-08-23 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Aggiornamento | CL King | Neutral → Buy |
| 2017-02-03 | Downgrade | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Ripresa | BofA/Merrill | Neutral |
| 2016-08-16 | Reiterato | Stifel | Buy |
| 2016-08-03 | Aggiornamento | Northcoast | Sell → Neutral |
| 2016-07-20 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-19 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-01 | Iniziato | CL King | Neutral |
| 2016-03-21 | Reiterato | Stifel | Buy |
| 2016-02-04 | Iniziato | Credit Suisse | Outperform |
| 2015-10-29 | Reiterato | Stifel | Buy |
| 2015-08-28 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Reiterato | Stifel | Buy |
| 2015-07-23 | Reiterato | Canaccord Genuity | Buy |
Mostra tutto
Idexx Laboratories Inc Borsa (IDXX) Ultime notizie
Idexx Laboratories stock hits all-time high at 735.31 USD By Investing.com - Investing.com Nigeria
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 10 Years - Benzinga
Palmetto Grain Brokerage - Palmetto Grain Brokerage
What Are Wall Street Analysts' Target Price for IDEXX Laboratories Stock? - inkl
Can IDEXX Laboratories Inc. (IX1) stock retain market dominanceWeekly Trade Analysis & Fast Exit and Entry Strategy Plans - newser.com
Is IDEXX Laboratories Inc. stock cheap at current valuationJuly 2025 Trade Ideas & Daily Stock Momentum Reports - newser.com
Why IDEXX Laboratories Inc. stock could benefit from AI revolutionWeekly Trend Summary & Risk Controlled Stock Pick Alerts - newser.com
Is IDEXX Laboratories Inc. stock attractive for ETFsCEO Change & Momentum Based Trading Signals - newser.com
Idexx Laboratories (IDXX) Recently Broke Out Above the 20-Day Moving Average - Yahoo Finance
Will IDEXX Laboratories Inc. stock outperform growth indexes2025 Top Gainers & Technical Pattern Based Signals - newser.com
How robust is IDEXX Laboratories Inc. (IX1) stock financial positionWeekly Stock Report & AI Forecasted Entry/Exit Points - newser.com
Why IDEXX Laboratories Inc. stock is a must watch in 2025Portfolio Risk Report & Intraday High Probability Alerts - newser.com
Why IDEXX Laboratories Inc. (IX1) stock stays undervaluedTrade Performance Summary & AI Powered Buy/Sell Recommendations - newser.com
Quantitative breakdown of IDEXX Laboratories Inc. recent moveTrade Risk Assessment & Precise Entry and Exit Recommendations - newser.com
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
Best Manufacturing: IDEXX Horizon Center - Engineering News-Record | ENR
Does IDEXX Laboratories Inc. fit your quant trading modelWeekly Stock Report & Risk Controlled Swing Alerts - newser.com
Why retail investors favor IDEXX Laboratories Inc. stockWeekly Gains Report & Fast Exit Strategy with Risk Control - newser.com
William Blair Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating - 富途牛牛
Idexx Laboratories Inc Azioni (IDXX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):